背内侧前额叶间歇性θ爆发刺激与预期驱动的安慰剂情绪效应:一项随机临床试验
该随机临床试验采用受试者内交叉设计,纳入50名未服药的抑郁症状成人,比较背内侧前额叶间歇性、连续性和伪θ爆发刺激对安慰剂fMRI任务中预期与情绪反应的影响。结果显示间歇性θ爆发刺激增强默认模式网络激活并放大安慰剂诱导的情绪改善,提示默认模式网络可塑性参与抗抑郁预期效应的快速塑造。
要点
- 间歇性θ爆发刺激背内侧前额叶可增强默认模式网络激活并放大安慰剂情绪改善。
- 默认模式网络激活越高,间歇性刺激下预期相关情绪反应越强。
- 连续性θ爆发刺激相对其他条件提高了预期评分。
核心结论
- 单次间歇性θ爆发刺激靶向背内侧前额叶可增强默认模式网络的预期相关调制并放大安慰剂诱导的情绪改善。
- 默认模式网络可塑性可能参与抗抑郁预期效应的快速塑造,并提示增敏治疗反应的环路机制。
研究设计与样本
- 随机临床试验,采用受试者内、交叉平衡设计,于2020年10月至2025年3月开展。
- 纳入18至53岁未服用精神药物的抑郁症状成人,招募自匹兹堡大学医学中心。
- 共103人入组,67人完成至少1次 session,最终分析样本50人(平均[SD]年龄28.3[9.5]岁;男性26人[52.0%])。
- 干预为背内侧前额叶三次θ爆发刺激 session(脑电坐标F2;80%静息运动阈值,间隔1周):间歇性、连续性和伪刺激。
- 刺激后1小时完成抗抑郁安慰剂功能磁共振成像任务,通过预期线索和伪神经反馈操纵预期信念。
主要发现
- 基于聚类的分析确认刺激主效应呈显著单调模式(间歇性>伪刺激>连续性,F2,144=4.55;P=.01;η2=0.06)。
- 预测情绪的模型中,默认模式网络激活越高,间歇性刺激相比伪刺激下预期相关情绪反应越强(β=0.30;95%可信区间0.07-0.52)。
- 预测预期的模型中,默认模式网络激活越高,对治疗线索的预期评分越高(β=0.38;95%可信区间0.22-0.55),但该耦合在连续性刺激下最强(β=-0.22;95%可信区间-0.44至0)。
- 行为学上,连续性刺激相对其他条件提高了预期评分。
关键数值与推荐
- 体素分析显示间歇性相比连续性刺激增加默认模式网络内背内侧前额叶活动,但阈值自由聚类增强校正P=.98。
临床怎么用
- 结果提示间歇性θ爆发刺激背内侧前额叶可能通过增强默认模式网络预期相关调制来放大安慰剂情绪改善。
- 连续性刺激提高预期评分但未增强安慰剂情绪效应,提示不同刺激模式对预期与情绪环路的分离作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Default mode network (DMN) activity has been implicated in mechanisms of antidepressant treatment response, particularly expectancy processes that contribute to placebo effects. However, causal evidence is limited. OBJECTIVE: To test whether modulating DMN function via theta burst stimulation (TBS) over the dorsomedial prefrontal cortex (PFC) alters placebo-related neural activity and expectancy-driven mood responses. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical trial was conducted from October 2020 to March 2025 and represented a within-person, counterbalanced design. Adults with depressive symptoms aged 18 to 53 years not taking psychotropic medication were included in the analysis. Participants were recruited from the University of Pittsburgh Medical Center. Trial × trial expectancy and mood ratings were recorded. Data analysis was performed on a rolling basis from October 2021 to March 2025. INTERVENTIONS: Three TBS sessions over the dorsomedial PFC (electroencephalogram coordinate F2; 80% resting motor threshold, 1 week apart): intermittent (iTBS), continuous (cTBS), and sham (sTBS). One hour later, they completed the antidepressant placebo functional magnetic resonance imaging (MRI) task, which manipulated anticipatory beliefs using expectancy cues and sham neurofeedback. MAIN OUTCOMES AND MEASURES: Outcomes included expectancy and mood ratings during the antidepressant placebo functional MRI task and placebo-related neural activation in the DMN. RESULTS: A total of 103 individuals were enrolled in the study. Of those enrolled, 67 completed at least 1 session, and 50 (mean [SD] age, 28.3 [9.5] years; 26 male [52.0%]) composed the final analytic sample. Voxelwise analyses showed that iTBS increased dorsomedial PFC activity relative to cTBS in the DMN (threshold-free cluster enhancement corrected P = .98). Cluster-based analyses confirmed a main effect of stimulation, with a significant monotonic pattern (iTBS > sTBS > cTBS, F2,144 = 4.55; P = .01; η2 = 0.06). In models predicting mood, greater DMN activation predicted stronger expectancy-related mood responses under iTBS compared with sTBS (β = 0.30; 95% credible interval [CrI], 0.07-0.52). In contrast, in models predicting expectancies, greater DMN activation predicted higher expectancy ratings in response to the treatment cue (β = 0.38; 95% CrI, 0.22-0.55), but this coupling was strongest under cTBS (β = -0.22; 95% CrI, -0.44 to 0), likely reflecting engagement of upstream regions. Behaviorally, cTBS increased expectancy ratings relative to the other conditions. CONCLUSIONS AND RELEVANCE: Results of this randomized clinical trial show that a single session of iTBS targeting the dorsomedial PFC enhanced expectancy-related modulation of the DMN and amplified placebo-induced mood improvement. These findings implicate DMN plasticity in the rapid shaping of antidepressant expectancy effects and highlight a potential circuit-based mechanism for augmenting treatment response in depression. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04276259.
引用
- Snyder I, Handoko K, Neppach A, et al. Intermittent Theta Burst Stimulation of the Dorsomedial PFC and Expectancy-Driven Placebo Mood Effects: A Randomized Clinical Trial. JAMA Psychiatry. 2026. PMID: 42090145. doi:10.1001/jamapsychiatry.2026.0647
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。